Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 838632, 9 pages
http://dx.doi.org/10.1155/2014/838632
Research Article

CD163+ Tumor-Associated Macrophages Correlated with Poor Prognosis and Cancer Stem Cells in Oral Squamous Cell Carcinoma

1The State Key Laboratory Breeding Base of Basic Science of Stomatology and Key Laboratory of Oral Biomedicine Ministry of Education, Wuhan University, Wuhan 430079, China
2Department of Oral Maxillofacial-Head Neck Oncology, School and Hospital of Stomatology, Wuhan University, Wuhan 430079, China

Received 16 February 2014; Revised 5 April 2014; Accepted 6 April 2014; Published 6 May 2014

Academic Editor: Yi-Fang Ping

Copyright © 2014 Ke-Fei He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Quan, N. W. Johnson, G. Zhou, P. G. Parsons, G. M. Boyle, and J. Gao, “Potential molecular targets for inhibiting bone invasion by oral squamous cell carcinoma: a review of mechanisms,” Cancer and Metastasis Reviews, vol. 31, no. 1-2, pp. 209–219, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. J. E. Visvader and G. J. Lindeman, “Cancer stem cells: current status and evolving complexities,” Cell Stem Cell, vol. 10, no. 6, pp. 717–728, 2012. View at Publisher · View at Google Scholar
  4. J. D. Lathia, J. M. Heddleston, M. Venere, and J. N. Rich, “Deadly teamwork: neural cancer stem cells and the tumor microenvironment,” Cell Stem Cell, vol. 8, no. 5, pp. 482–485, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-C. Wang, Y.-T. Yo, H.-Y. Lee et al., “ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome,” American Journal of Pathology, vol. 180, no. 3, pp. 1159–1169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Sonobe, H. Miyamoto, B. Nobukawa et al., “Prognostic value of CD44 isoform expression in thymic epithelial neoplasms,” Cancer, vol. 103, no. 10, pp. 2015–2022, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. X. B. Tang, X. H. Shen, L. Li, Y. F. Zhang, and G. Q. Chen, “SOX2 overexpression correlates with poor prognosis in laryngeal squamous cell carcinoma,” Auris Nasus Larynx, vol. 40, no. 5, pp. 481–486, 2013. View at Publisher · View at Google Scholar
  8. L. Du, Y. Yang, X. Xiao et al., “Sox2 nuclear expression is closely associated with poor prognosis in patients with histologically node-negative oral tongue squamous cell carcinoma,” Oral Oncology, vol. 47, no. 8, pp. 709–713, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Liu, B. Lin, M. Zhao et al., “The multiple roles for Sox2 in stem cell maintenance and tumorigenesis,” Cellular Signalling, vol. 25, no. 5, pp. 1264–1271, 2013. View at Publisher · View at Google Scholar
  10. E. Fessler, F. E. Dijkgraaf, E. M. F. de Sousa, and J. P. Medema, “Cancer stem cell dynamics in tumor progression and metastasis: Is the microenvironment to blame?” Cancer Letters, vol. 34, no. 1, pp. 97–104, 2013. View at Publisher · View at Google Scholar
  11. X. Tang, C. Mo, Y. Wang, D. Wei, and H. Xiao, “Anti-tumour strategies aiming to target tumour-associated macrophages,” Immunology, vol. 138, no. 2, pp. 93–104, 2013. View at Publisher · View at Google Scholar
  12. R. A. Signer and S. J. Morrison, “Mechanisms that regulate stem cell aging and life span,” Cell Stem Cell, vol. 12, no. 2, pp. 152–165, 2013. View at Publisher · View at Google Scholar
  13. N. B. Hao, M. H. Lu, Y. H. Fan, Y. L. Cao, Z. R. Zhang, and S. M. Yang, “Macrophages in tumor microenvironments and the progression of tumors,” Clinical and Developmental Immunology, vol. 2012, Article ID 948098, 11 pages, 2012. View at Publisher · View at Google Scholar
  14. C. Shi and E. G. Pamer, “Monocyte recruitment during infection and inflammation,” Nature Reviews Immunology, vol. 11, no. 11, pp. 762–774, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. B. Maniecki, A. Etzerodt, B. P. Ulhøi et al., “Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells,” International Journal of Cancer, vol. 131, no. 10, pp. 2320–2331, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. D. M. Richards, J. Hettinger, and M. Feuerer, “Monocytes and macrophages in cancer: development and functions,” Cancer Microenvironment, vol. 6, no. 2, pp. 179–191, 2013. View at Google Scholar
  17. M. de Palma and C. E. Lewis, “Macrophage regulation of tumor responses to anticancer therapies,” Cancer Cell, vol. 23, no. 3, pp. 277–286, 2013. View at Publisher · View at Google Scholar
  18. C. Medrek, F. Ponten, K. Jirstrom, and K. Leandersson, “The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients,” BMC Cancer, vol. 12, article 306, 2012. View at Google Scholar
  19. C. F. Huang, L. Zhang, S. R. Ma et al., “Clinical significance of Keap1 and Nrf2 in oral squamous cell carcinoma,” PLoS ONE, vol. 8, no. 12, Article ID e83479, 2013. View at Google Scholar
  20. Z. J. Sun, L. Zhang, B. Hall, Y. Bian, J. S. Gutkind, and A. B. Kulkarni, “Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model,” Clinical Cancer Research, vol. 18, no. 19, pp. 5304–5313, 2012. View at Publisher · View at Google Scholar
  21. N. Takakura, “Formation and regulation of the cancer stem cell niche,” Cancer Science, vol. 103, no. 7, pp. 1177–1181, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Ruffell, N. I. Affara, and L. M. Coussens, “Differential macrophage programming in the tumor microenvironment,” Trends in Immunology, vol. 33, no. 3, pp. 119–126, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Joyce and J. W. Pollard, “Microenvironmental regulation of metastasis,” Nature Reviews Cancer, vol. 9, no. 4, pp. 239–252, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. J. A. McCubrey, L. S. Steelman, S. L. Abrams et al., “Targeting the cancer initiating cell: the ultimate target for cancer therapy,” Current Pharmaceutical Design, vol. 18, no. 13, pp. 1784–1795, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Y. Bourguignon, G. Wong, C. Earle, and L. Chen, “Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma,” The Journal of Biological Chemistry, vol. 287, no. 39, pp. 32800–32824, 2012. View at Publisher · View at Google Scholar
  26. M. Zeyda, K. Gollinger, J. Todoric et al., “Osteopontin is an activator of human adipose tissue macrophages and directly affects adipocyte function,” Endocrinology, vol. 152, no. 6, pp. 2219–2227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. D. E. Sanford, B. A. Belt, R. Z. Panni et al., “Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis,” Clinical Cancer Research, vol. 19, no. 13, pp. 3404–3415, 2013. View at Publisher · View at Google Scholar
  28. Y. Komohara, K. Ohnishi, J. Kuratsu, and M. Takeya, “Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas,” Journal of Pathology, vol. 216, no. 1, pp. 15–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Shabo, O. Stål, H. Olsson, S. Doré, and J. Svanvik, “Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival,” International Journal of Cancer, vol. 123, no. 4, pp. 780–786, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. I. Shabo, H. Olsson, X.-F. Sun, and J. Svanvik, “Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time,” International Journal of Cancer, vol. 125, no. 8, pp. 1826–1831, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Q. Kong, X. D. Zhu, H. X. Xu et al., “The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma,” PLoS ONE, vol. 8, no. 3, Article ID e59771, 2013. View at Google Scholar
  32. J. Yang, D. Liao, C. Chen et al., “Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway,” Stem Cells, vol. 31, no. 2, pp. 248–258, 2013. View at Publisher · View at Google Scholar
  33. M. Jinushi, S. Chiba, H. Yoshiyama et al., “Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 30, pp. 12425–12430, 2011. View at Publisher · View at Google Scholar · View at Scopus